Colirest: Phase II

INKP said that among 11 evaluable patients with mild or moderate active ulcerative colitis in

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE